Status:

RECRUITING

Glioblastoma Remote Monitoring and Care - Research Protocol

Lead Sponsor:

Case Comprehensive Cancer Center

Conditions:

Glioblastoma

Venous Thromboembolism

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this research is to learn more about how what the Apple watch measures, in terms of walking data, heart rate, breathing rate, and sleep habits, relates to how participants feel. During ...

Detailed Description

Glioblastoma is the most common primary malignant brain tumor in adults, with a near-universal rate of recurrence, and reports low median survivals of between 14 and 18 months, even with maximal thera...

Eligibility Criteria

Inclusion

  • newly-diagnosed or recurrent glioblastoma undergoing treatment or active surveillance
  • at least 18 years of age at the time of study enrolment
  • Karnofsky Performance Status (KPS) ≥ 70% at time of study enrolment
  • able to comprehend informed consent form and provide informed consent
  • access to patient or caregiver's own Apple iPhone to interface with watch application for documentation of symptoms

Exclusion

  • under 18 years of age at the time of study enrolment
  • inability to give informed consent due to aphasia or other language barrier
  • tattoos located on the skin of the wrist or forearm where the Apple Watch will be placed or other skin conditions preventing adequate sensor function
  • inability to tolerate Apple Watch for at least 12 hours per day on at least 50% of days in a four-week period
  • no access to patient or caregiver Apple iPhone to document symptoms

Key Trial Info

Start Date :

April 30 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2027

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT06129760

Start Date

April 30 2024

End Date

December 1 2027

Last Update

July 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center

Cleveland, Ohio, United States, 44195

Glioblastoma Remote Monitoring and Care - Research Protocol | DecenTrialz